SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced commercial availability of a new high throughput single-cell mRNA sequencing workflow for its C1TM system to enable large-scale studies to characterize heterogeneous samples. This validated workflow includes a new advanced integrated fluidic circuit (IFC) and reagent kit that significantly increases throughput and ease-of-use, while simultaneously […]
PLEASANTON, Calif. — Roche (SIX: RO, ROG; OTCQX: RHHBY) has signed a definitive asset purchase agreement with Lumora for products associated with the unique, patent-protected Heat Elution1technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded (FFPE) tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution. Today, […]
Cambridgeshire, UK — Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical research and industrial markets, has sold its proprietary nucleic acid Heat Elution purification technology1 to Roche. Roche has signed a definitive Asset Purchase Agreement with Lumora for products associated with its proprietary nucleic acid Heat Elution purification technology that is designed […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has signed a definitive agreement to acquire Kapa Biosystems, Inc. (Kapa) a privately-held company headquartered in Wilmington, Massachusetts, US. Kapa Biosystems is a provider of genomic tools in the life sciences sector that employs proprietary technologies to optimize enzymes for next-generation sequencing (NGS), as well as […]
BOULDER, Colo.– ArcherDX launched Archer™ PreSeq™ QC Assays, which assess the quality of nucleic acid in FFPE samples prior to library creation for next-generation sequencing (NGS)-based mutation detection. “NGS is an extremely effective way to find oncogenic driver mutations in a tumor specimen, but analytical sensitivity and specificity are dependent upon the quality of the […]
BEIJING and FREMONT, Calif. — Annoroad has selected the WaferGen Bio-systems, Inc. (Nasdaq:WGBS) SmartChip platform for high-throughput target enrichment of BRCA1 and BRCA2 genes, SNP genotyping services and library quantification for next-generation sequencing (NGS). The system will provide the performance and flexibility to streamline key applications onto a single platform. NGS-based applications for cancer discovery […]
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) recently introduced a new product to help food-safety labs more accurately test high-fat samples. The new product, Agilent Bond Elut Enhanced Matrix Removal-Lipid, uses an innovative sorbent technology that gives food-safety labs a better way to address what has been one of their most challenging tasks. […]
Rochester, NY — Diffinity Genomics, a Henrietta-based biotech company backed by venture capital fund Excell Partners and High Tech Rochester incubator, has been acquired by global life science company Chiral Technologies, Inc. Both Excell Partners and High Tech Rochester are affiliates of the University of Rochester where the technology originated. Diffinity has developed DNA purification […]
WEST CHESTER, PA – Chiral Technologies, part of DAICEL CORPORATION, the global market leader in enantioselective chromatography, is pleased to announce the acquisition of the assets of Diffinity Genomics® of West Henrietta, N.Y. Diffinity Genomics has developed novel technology for the purification of nucleic acids, which formed the foundation for their products in DNA purification […]
PLEASANTON, Calif.–10X Genomics today announced immediate availability of Linked-Read data generated by the GemCode™ Platform using several NIST reference samples. NIST is the federal agency developing measurements and standards under the U.S. Department of Commerce. As part of the NIST Genome in a Bottle (GIAB) Consortium, 10X Genomics is adding to the technical infrastructure enabling […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
